E. Di Francesco

Vascular Endothelial Growth Factor and Thrombopoietin in Patients with Essential Thrombocythemia and Polycythemia vera and Thrombotic Complications

R. Cacciola, E. Cacciola, R. Giustolisi, 2003, Acta Haematologica.

Percutaneous transluminal aortic valve implantation for severe aortic valve stenosis in a patient with severe haemophilia A

F. Di Raimondo, F. Raimondo, G. Giuffrida, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Percutaneous transluminal angioplasty and stent implantation for aortic coarctation in haemophilia A patient with high‐titre factor VIII inhibitors

F. Di Raimondo, F. Raimondo, G. Giuffrida, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report

F. Di Raimondo, A. Fiumara, G. Giuffrida, 2016, Journal of Medical Case Reports.

Treatment of symptomatic patients with essential thrombocythemia: Effectiveness of anagrelide

A. Cipolla, R. Cacciola, E. Cacciola, 2005, American journal of hematology.

Effect of Anagrelide on Platelet Coagulant Function in Patients with Essential Thrombocythemia

D. Tibullo, F. Pezzella, R. Cacciola, 2007, Acta Haematologica.

Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic complications.

R. Cacciola, E. Cacciola, R. Giustolisi, 2002, Haematologica.